| Application no. and date | 11712881.9 (espacenet) (Federated) (European Patent Register), 20110408 | | Patent/reg. no. and date | DK/EP 2558448, 20150520 | | Publication date | 20130220 | | Priority no. and date | EP 10004022, 20100415 | | EP pub. no. and date |
EP 2558448 20130220 | | Effective date | | | Applicant/owner | Bayer HealthCare LLC, 100 Bayer Boulevard
Whippany, NJ 07981, US | | Applicant ref. no. | BBS BHC101004PCT-EP | | Inventor | HEILMANN, Werner, Am Ringofen 21
42327 Wuppertal, DE,
REHSE, Joachim, Am Kloster 12
42799 Leichlingen, DE,
LÖGERS, Michael, Niederradenberg 15
42327 Wuppertal, DE,
STIEHL, Juergen, Rosenstr. 28
45549 Sprockhövel, DE,
GOTTFRIED, Michael, Herzogstr. 44
42103 Wuppertal, DE,
WICHMANN, Saskia, Nestorstr. 56
10709 Berlin, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07D 213/81 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLING AF 4-{4-[({[4-CHLOR-3-(TRIFLUORMETHYL)-PHENYL]AMINO}CARBONYL)AMINO]-3-FLUORPHENOXY}-N-METHYLPYRIDIN-2-CARBOXAMID, DETS SALTE OG MONOHYDRAT | | Int. application no. | EP2011055508 | | Int. publication no. | WO2011128261 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
